APA (7th ed.) Citation

Molina-Hinojosa, C. L., Carreras-Collado, R., Saumoy-Linares, M., Peñafiel, J., Heydari, F., Martí, J. C., & Fernández-Montolí, M. E. (2026). Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study. Cancers, 18(11), 1695. https://doi.org/10.3390/cancers18111695

Chicago Style (17th ed.) Citation

Molina-Hinojosa, Christian Leonardo, Ramón Carreras-Collado, María Saumoy-Linares, Judith Peñafiel, Fatima Heydari, Joan Climent Martí, and María Eulalia Fernández-Montolí. "Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed Vs. Immunocompetent Women: A 20-Year Cohort Study." Cancers 18, no. 11 (2026): 1695. https://doi.org/10.3390/cancers18111695.

MLA (9th ed.) Citation

Molina-Hinojosa, Christian Leonardo, et al. "Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed Vs. Immunocompetent Women: A 20-Year Cohort Study." Cancers, vol. 18, no. 11, 2026, p. 1695, https://doi.org/10.3390/cancers18111695.